Aditya Raghunathan
Overview
Explore the profile of Aditya Raghunathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
3022
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neth B, Kraft R, Eschbacher K, Johnson D, Decker P, Sener U, et al.
J Neurooncol
. 2025 Mar;
PMID: 40048040
Purpose: Primary gliomas arising within midline structures of the central nervous system are associated with a worse prognosis compared with hemispheric gliomas. In adults, compared to their pediatric counterparts, adult...
2.
Molecular profile of adult primary leptomeningeal gliomatosis aligns with glioblastoma, IDH-wildtype
Zhu Y, Carabenciov D, Johnson D, Trejo-Lopez J, Nguyen A, Raghunathan A, et al.
Brain Pathol
. 2024 Dec;
:e13326.
PMID: 39692003
Adult primary leptomeningeal gliomatosis (PLG) is a rare, rapidly progressive and fatal disease characterized by prominent leptomeningeal infiltration by a glial tumor without an identifiable parenchymal mass. The molecular profile...
3.
Syc-Mazurek S, Liu M, Vasquez A, Raghunathan A, Keating G, Youssef P
Neurology
. 2024 Aug;
103(6):e209791.
PMID: 39167751
No abstract available.
4.
Vizcaino M, Giannini C, Vaubel R, Nguyen A, Trejo-Lopez J, Raghunathan A, et al.
J Neuropathol Exp Neurol
. 2024 Jul;
83(12):1003-1009.
PMID: 39042515
Pleomorphic xanthoastrocytomas (PXAs) harbor CDKN2A homozygous deletion in >90% of cases, resulting in loss of p16 expression by immunohistochemistry. Considering the proximity of MTAP to CDKN2A and their frequent concurrent...
5.
Carr C, Van Gompel J, Raghunathan A
AJNR Am J Neuroradiol
. 2024 Jun;
45(8):E30.
PMID: 38937116
No abstract available.
6.
Webb L, Neth B, Raghunathan A, Greipp P, Ida C, Carabenciov I, et al.
Neurologist
. 2024 May;
29(4):254-258.
PMID: 38797928
Introduction: Glioblastoma is a uniformly lethal primary central nervous system neoplasm. Despite the increased understanding of its pathophysiology and treatment advancements, median overall survival for patients with glioblastoma, IDH-wild type...
7.
Bhandarkar A, Bhandarkar S, Babovic-Vuksanovic D, Raghunathan A, Schwartz J, Spinner R
J Neurooncol
. 2024 May;
169(1):147-153.
PMID: 38739187
Purpose: Selumetinib is an FDA-approved targeted therapy for plexiform neurofibromas in neurofibromatosis type 1(NF1) with durable response rates seen in most, but not all patients. In this proof-of-concept study, we...
8.
Hong S, Shinya Y, Mahajan A, Laack N, OBrien E, Stokken J, et al.
Neurosurg Focus
. 2024 May;
56(5):E4.
PMID: 38691852
Objective: This study aimed to provide data on extended outcomes in primary clival chordomas, focusing on progression-free survival (PFS) and overall survival (OS). Methods: A retrospective single-center analysis was conducted...
9.
Nielson K, Rowsey R, Dasari S, Sukov W, Kipp B, Raghunathan A, et al.
Hum Pathol
. 2024 Apr;
146:57-65.
PMID: 38615998
Mucinous tubular and spindle cell carcinoma (MTSCC) shows significant overlap with papillary renal cell carcinoma (PRCC), and harbor recurrent copy-number alterations (CNA). We evaluated 16 RCC with features suggestive of...
10.
Bauman M, Graves J, Haller T, McMillan R, Routman D, Raghunathan A, et al.
J Neurosurg
. 2024 Mar;
141(3):711-719.
PMID: 38518294
Objective: Olfactory neuroblastoma (ONB) is a rare, malignant tumor of the sinonasal tract that arises from olfactory epithelium. Although surgery is the preferred first-line treatment, tumor involvement of adjacent structures...